BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This highly advanced material comprises folate and magnetic dual-targeted doxorubicin-loaded perfluorohexane phase-transition liposome nanoparticles (FA-PFH-Fe3O4@ADM). The complex internal architecture features an emulsion of volatile liquid perfluorohexane (PFH) along with hydrophilic doxorubicin hydrochloride (adriamycin/ADM) and superparamagnetic iron oxide (Fe3O4) nanoparticles encapsulated within a lipid vesicle shell, whose exterior surface is functionalized with folate (FA) ligands. When exposed to an external alternating magnetic field or acoustic stress in a laboratory assay, the magnetic nanoparticles generate localized heat that triggers a liquid-to-gas phase transition of the perfluorohexane core. This internal vaporization creates intense localized pressure that mechanically ruptures the lipid bilayer, providing a multi-responsive model for studying targeted, stimulus-induced burst-release mass transport phenomena.
Source
Custom synthesis
Functional Group
Folate; Magnetic component; Doxorubicin; Perfluorohexane
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.